Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Blood component therapy (author's transl)]

V Kretschmer

    Anasthesie, Intensivtherapie, Notfallmedizin
    |June 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Blood component therapy optimizes patient care by using specific blood products like packed red cells and fresh frozen plasma. Guidelines ensure efficient blood use and improved component quality for better transfusion outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Complexity of gap junctions between horizontal cells of the carp retina.

    Neuroscience·2016
    Same author

    [Effects of atypical employment on difficulties in falling asleep and maintaining sleep - gender differences in the lidA study].

    Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2015
    Same author

    Measures to prevent TRALI.

    Vox sanguinis·2007
    Same author

    Characterization of immune system alterations following preoperative autologous blood donation for elective hip replacement surgery.

    Transfusion medicine (Oxford, England)·2007
    Same author

    Maximum donation volumes per session in donor plasmapheresis.

    Vox sanguinis·2006
    Same author

    Prevention and diagnosis of delayed haemolytic transfusion reactions.

    Vox sanguinis·2006

    Area of Science:

    • Transfusion Medicine
    • Hematology

    Context:

    • Balancing individual patient needs with the general blood supply is crucial in blood component therapy.
    • Current practices involve strict guidelines for using blood products, including fresh whole blood, platelet units, and coagulation concentrates.

    Purpose:

    • To optimize blood component therapy by establishing guidelines for product utilization.
    • To enhance the quality of blood components to meet clinical demands.
    • To investigate optimal ratios for blood product transfusion, such as packed red cells to fresh frozen plasma.

    Summary:

    • Blood component therapy focuses on meeting patient needs while preserving the overall blood supply.
    • Recommendations include increased transfusion of packed red cells and fresh frozen plasma in a 3:1 ratio over whole blood.

    Related Experiment Videos

  • Production of buffy coat-poor erythrocyte concentrates with low viscosity is encouraged.

    • Impact:

    • Improved clinical outcomes through optimized blood component utilization.
    • Enhanced efficiency and sustainability of blood product resources.
    • Identifies areas for further research in transfusion medicine to address remaining questions.